cancer trial

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

cancer trial
Oct 8, 2024, 13:11 | Blog
Elisa Agostinetto: The practice-changing results of the HypoG-01 UNICANCER trial at ESMO24
Elisa Agostinetto shared a post by MediMix, on X, adding: ''At ESMO24 the practice-changing results…
Oct 1, 2024, 08:28 | Blog
Daniel Michaeli: Key takeaways from our new article on breast cancer drugs
Daniel Michaeli shared a post on LinkedIn, about a recently published paper: Breast cancer drugs:…
Sep 26, 2024, 15:35 | Blog
Jarushka Naidoo: TL01 Phase III Datopotamab-Deruxtecan vs Docetaxel in second-line NSCLC
Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…
Sep 26, 2024, 14:27 | Blog
Mehdi Hamadani: Efficacy of axatilimab in chronic graft-versus-host disease
Mehdi Hamadani shared a post on X, about recent paper published in The New England…
Sep 24, 2024, 23:18 | Blog
Giuseppe Lombardi: Pleased to announce the academic MIRAGE trial for patients with recurrent grade 2-3 meningioma
Giuseppe Lombardi, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared a…
Sep 24, 2024, 16:52 | Blog
Assessment of the safety and efficacy of Balstilimab in combination with Botensilimab for NSCLC - Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: ''Assessment of the safety and efficacy…
Sep 24, 2024, 11:46 | Blog
David Palma: Final results of ORATOR, after completion of the full follow-up period
David Palma shared a post on X, about recent paper published in Journal of Clinical…
Sep 22, 2024, 12:38 | Blog
Amol Akhade: Cabozantinib plus Atezolizumab vs second-line NHT in prostate cancer
Amol Akhade shared a post on LinkedIn: ''Cabozantinib plus Atezolizumab versus second-line Non-hormonal Therapy (NHT)…
Sep 21, 2024, 14:16 | Blog
Sabine D. Brookman-May: The right questions addressed by Petros Grivas after NIAGARA trial presentation
Sabine D. Brookman-May shared a post by Roberto Iacovelli, on X, adding: ''The right questions…
Sep 21, 2024, 13:07 | Blog
Olubukola Ayodele about HER2 low breast cancer
Olubukola Ayodele shared a post on LinkedIn: ''Let's talk about HER2 low breast cancer. The…
Sep 21, 2024, 13:02 | Blog
Final OS data from the phase III CONTACT-02 trial at ESMO24
ESMO (European Society for Medical Oncology) shared a post on LinkedIn: ''Final OS data from…
Sep 21, 2024, 09:03 | Blog
Neoadjuvant nivolumab with or without ipilimumab in early stage TNBC
Top Biomedical Science shared a post on X, about recent paper published in Nature Medicine:…
Sep 17, 2024, 16:11 | Blog
Amol Akhade: ESMO Presidential Today - Keynote 522 Shows Overall Survival
Amol Akhade shared a post on LinkedIn: ''ESMO presidential today. Keynote 522 shows overall survival…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Jul 29, 2024, 07:15 | Blog
Petros Grivas discusses the SURE -01 and the TROPICS-04 trials with Chandler Park
Chandler Park shared a post on X: ''Petros Grivas and I discuss the SURE -01 and…
Jul 20, 2024, 10:51 | Blog
Toni Choueiri: TiNivo2 results are out
Toni Choueiri shared a post on X: ''TiNivo2 results are out - adding PD1 inhibitor…
Jul 16, 2024, 23:34 | Blog
Integrating Clinical Trials and Practice - A New JAMA Series and Call for Papers
JAMA shared a post on X: ''JAMA invites articles for new article series, 'Integrating Clinical…
Jul 14, 2024, 22:08 | Blog
The primary endpoint has been reached in the EORTC-1333-GUCG/PEACE III Trial
EORTC (European Organisation for Research and Treatment of Cancer) shared a post on X: ''EORTC…
Jul 14, 2024, 06:27 | Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jul 11, 2024, 16:10 | Blog
Roupen Odabashian: Customer Service in Healthcare
Roupen Odabashian shared a post on LinkedIn: ''Customer Service in Healthcare. Today, for the first time…
Jul 8, 2024, 08:55 | Blog
Stefano Arcangeli: Our one-shot single-session radiotherapy for UIR and HR PCa is finally out on IJROBP - The Red Journal
Valeria Faccenda, Medical Physicist at IRCCS San Gerardo dei Tintori Foundation, shared a post by…
Jun 18, 2024, 18:23 | Insight
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Cancer trial participation not…
Jun 6, 2024, 00:54 | Blog
Discussing the practice changing LAURA trial - Two Onc Docs
Two Onc Docs shared a post on X/Twitter: ''Discussing the practice changing LAURA trial for…
May 16, 2024, 12:26 | Blog
Michael Chuong: The agenda for this pancreatic cancer conference looks great
Michael Chuong, Lead GI Radiation Oncologist at Miami Cancer Institute, shared on X/Twitter: ''The agenda…
May 14, 2024, 13:53 | Blog
John Edwards: Lots of debate about the MARS2 RCT of mesothelioma surgery since Eric Lim’s presentation at IASLC
John Edwards, Consultant Thoracic Surgeon at Sheffield Teaching Hospitals NHS Foundation Trust and Member Board…
May 5, 2024, 07:31 | Blog
Pavlos Msaouel: Interpreting randomized controlled trials
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a…
Apr 17, 2024, 17:16 | Insight
Rafeh Naqash: Fantastic discussion on biomarker testing and precison oncology
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, replied to the post of Rafeh…
Apr 3, 2024, 06:35 | Opinion
Pashtoon Kasi: ctDNA kinetics is going to be an important variable to look at in patients getting novel immunotherapy drugs like the BOT/BAL on our NEST trial
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X/Twitter: ''ctDNA…
All: 28 Posts: 1 - 100
Special Coverage